Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $4K invested in Bio Green Med Solution Inc Preferred Stock in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more capital invested
Capital invested by funds: $4K → $4K ($0)
0.04% less ownership
Funds ownership: 0.19% → 0.15% (-0.04%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$830 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $4K | -$830 | -126 | -20% |
|
BGMSP Hedge Fund Activity: Q2 2022 in Review
1 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q2 2022, worth a combined $4K — unchanged from a quarter earlier.
Fund positioning in BGMSP was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $830.
- 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $4K of Bio Green Med Solution Inc Preferred Stock stock for Q2 2022, unchanged quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q2 2022 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q2 2022 was UBS Group, an estimated $830 sold.
Based on aggregated 13F filings for Q2 2022.